WO2000057836A3 - Cosmetic or dermatological compositions containing at least one substance for increasing the functionality and/or expression of cd44 membrane receptors of skin cells - Google Patents

Cosmetic or dermatological compositions containing at least one substance for increasing the functionality and/or expression of cd44 membrane receptors of skin cells Download PDF

Info

Publication number
WO2000057836A3
WO2000057836A3 PCT/FR2000/000764 FR0000764W WO0057836A3 WO 2000057836 A3 WO2000057836 A3 WO 2000057836A3 FR 0000764 W FR0000764 W FR 0000764W WO 0057836 A3 WO0057836 A3 WO 0057836A3
Authority
WO
WIPO (PCT)
Prior art keywords
skin cells
collagen
functionality
expression
increasing
Prior art date
Application number
PCT/FR2000/000764
Other languages
French (fr)
Other versions
WO2000057836A2 (en
Inventor
Marc Dumas
Frederic Bonte
Original Assignee
Dior Christian Parfums
Marc Dumas
Frederic Bonte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dior Christian Parfums, Marc Dumas, Frederic Bonte filed Critical Dior Christian Parfums
Priority to EP00915224A priority Critical patent/EP1165035B1/en
Priority to DE60023467T priority patent/DE60023467T2/en
Priority to JP2000607587A priority patent/JP4708571B2/en
Publication of WO2000057836A2 publication Critical patent/WO2000057836A2/en
Publication of WO2000057836A3 publication Critical patent/WO2000057836A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the uses in cosmetics or pharmaceuticals of at least one active agent for increasing the expression and/or functionality of CD44 membrane receptors of skin cells, enabling the fixation of hyaluronic acid and/or colagen, especially collage I and/or collagen IV and/or fibronectin on the surface of said skin cells. Preferably, said active agents are alpha hydroxyl acids or alpha ceto acids or salts and esters of said acids or manganese chloride. The inventive cosmetic or pharmaceutical compositions improve fixation of hyaluronic acid and/or collagen, especially collagen I or collagen IV and/or fibronectin on the surface of skin cells and improve hydration of the dermis and epidermis and prevent or treat skin-ageing phenomena and inflammatory phenomena.
PCT/FR2000/000764 1999-03-26 2000-03-27 Cosmetic or dermatological compositions containing at least one substance for increasing the functionality and/or expression of cd44 membrane receptors of skin cells WO2000057836A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP00915224A EP1165035B1 (en) 1999-03-26 2000-03-27 Cosmetic compositions containing at least one substance for increasing the functionality and/or expression of cd44 membrane receptors of skin cells
DE60023467T DE60023467T2 (en) 1999-03-26 2000-03-27 COSMETIC COMPOSITIONS CONTAINING AT LEAST ONE SUBSTANCE FOR IMPROVING THE OPERATIONAL AND / OR INCREASING THE EXPRESSION OF THE MEMBRANE RECEPTOR CD44 IN SKIN CELLS
JP2000607587A JP4708571B2 (en) 1999-03-26 2000-03-27 Cosmetic or dermatological composition containing at least one substance for increasing the functionality and / or expression of skin cell CD44 membrane receptor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR99/03840 1999-03-26
FR9903840A FR2791260B1 (en) 1999-03-26 1999-03-26 COSMETIC OR DERMATOLOGICAL COMPOSITIONS CONTAINING AT LEAST ONE SUBSTANCE FOR INCREASING THE FUNCTIONALITY AND / OR EXPRESSION OF CD44 MEMBRANE RECEPTORS OF SKIN CELLS

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09937507 A-371-Of-International 2001-09-26
US10/650,965 Continuation US20040043047A1 (en) 1999-03-26 2003-08-29 Cosmetic or dermatological compositions containing at least one substance for increasing the functionality and/or expression of the CD44 membrane receptors of skin cells

Publications (2)

Publication Number Publication Date
WO2000057836A2 WO2000057836A2 (en) 2000-10-05
WO2000057836A3 true WO2000057836A3 (en) 2001-05-17

Family

ID=9543712

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2000/000764 WO2000057836A2 (en) 1999-03-26 2000-03-27 Cosmetic or dermatological compositions containing at least one substance for increasing the functionality and/or expression of cd44 membrane receptors of skin cells

Country Status (6)

Country Link
EP (1) EP1165035B1 (en)
JP (1) JP4708571B2 (en)
DE (1) DE60023467T2 (en)
ES (1) ES2250118T3 (en)
FR (1) FR2791260B1 (en)
WO (1) WO2000057836A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2807655B1 (en) * 2000-04-18 2005-05-20 Oreal USE OF DIVALENT MANGANESE SALTS AS DEODORANT ASSETS IN COSMETIC COMPOSITIONS
FR2809005B1 (en) * 2000-05-18 2002-12-27 Oreal USE OF MANGANESE IN THE TREATMENT OF WRINKLES
FR2856296B1 (en) * 2003-06-18 2007-09-07 Jean Noel Thorel A COSMETIC CARE PROCESS WHICH CONJUGES A MECHANICAL EFFECT RESULTING FROM MASSAGE TO BIOLOGICAL EFFECTS IN COMPLEMENT OR RELAY
ATE504297T1 (en) * 2005-03-12 2011-04-15 Unilever Nv VISNADIN FOR THE TREATMENT OF ITCH OF THE SCALP
DE102005012554A1 (en) 2005-03-16 2006-09-28 Beiersdorf Ag Cosmetic preparation with hyaluronic acid
WO2007004300A1 (en) * 2005-07-06 2007-01-11 Dr.Ci:Labo Co., Ltd. Cosmetic product
DE102005057593A1 (en) * 2005-07-08 2007-01-11 Schwan-Stabilo Cosmetics Gmbh & Co. Kg Preparation, in particular cosmetic preparation, and their preparation and use
EP2049077B1 (en) * 2006-07-03 2010-12-01 L'Oréal Composition comprising at least one c-glycoside derivative and at least one hyaluronic acid and its cosmetic use
FR2945943B1 (en) * 2009-06-01 2015-04-03 Lvmh Rech USE OF A VEGETABLE EXTRACT RICH IN POLYPHENOLS AS ANTIOXIDANT AGENT IN ASSOCIATION WITH A HYDRATING OR HUMICIZING AGENT
JP5675178B2 (en) * 2010-06-09 2015-02-25 大島　光宏 Collagen degradation inhibitor
KR102397975B1 (en) * 2015-09-10 2022-05-12 주식회사 엘지생활건강 External composition for moisturizing of skin comprising kirenol
JP7016117B2 (en) 2016-01-18 2022-02-21 コスメディ製薬株式会社 Collagen cosmetics
JP2020152717A (en) * 2019-03-12 2020-09-24 株式会社ナノエッグ Toning lotion for sensitive skin
WO2021037383A1 (en) * 2019-08-30 2021-03-04 Symrise Ag COSMETIC USE OF β-L-ASPARTYL-L-ARGININE
CN114617792B (en) * 2022-03-28 2022-11-18 水羊化妆品制造有限公司 Anti-aging composition, preparation method and application thereof, and anti-aging skin care product
CN115869234B (en) * 2023-02-14 2023-05-12 北京世纪伟信医药科技有限公司 Recombinant human collagen mask with repairing activity and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019228A1 (en) * 1994-12-21 1996-06-27 Cosmederm Technologies Formulations and methods for reducing skin irritation
EP0756866A1 (en) * 1995-07-31 1997-02-05 L'oreal Use of benzoic acid derivatives for stimulating the renew of the epidermis and for treating the skin
EP0770399A2 (en) * 1986-12-23 1997-05-02 Eugene J. Dr. Van Scott Additives enhancing topical actions of therapeutic agents
WO1998017320A1 (en) * 1991-07-03 1998-04-30 Hyal Pharmaceutical Corporation Use of hyaluronan in gene therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3327840C1 (en) * 1983-08-02 1984-09-20 Blendax Werke Schneider Co Skin care products
JPH02169511A (en) * 1988-12-21 1990-06-29 Kanebo Ltd Skin cosmetic
CA2178964A1 (en) * 1993-12-15 1995-06-22 John A. Duffy Novel retinoid conjugate compounds and methods for treating skin aging
JPH0959141A (en) * 1995-08-24 1997-03-04 Lion Corp Dermal composition for external use
JP3608059B2 (en) * 1995-12-05 2005-01-05 株式会社アドバンス Cosmetics
US6086789A (en) * 1996-03-18 2000-07-11 Case Western Reserve University Medical uses of pyruvates
FR2751537B1 (en) * 1996-07-26 2004-04-16 Oreal USE OF HONEY AS A KERATOLYTIC AGENT, PARTICULARLY FOR IMPROVING THE RADIANCE OF THE SKIN AND TREATING WRINKLES
JPH10265362A (en) * 1997-03-19 1998-10-06 Yakult Honsha Co Ltd Cosmetic
WO2000013661A1 (en) * 1998-09-10 2000-03-16 Avon Products, Inc. Method and compositions for reducing dermatological aging and for reducing bruising
US6521237B2 (en) * 1998-11-12 2003-02-18 Johnson & Johnson Consumer Companies, Inc. Skin care composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0770399A2 (en) * 1986-12-23 1997-05-02 Eugene J. Dr. Van Scott Additives enhancing topical actions of therapeutic agents
WO1998017320A1 (en) * 1991-07-03 1998-04-30 Hyal Pharmaceutical Corporation Use of hyaluronan in gene therapy
WO1996019228A1 (en) * 1994-12-21 1996-06-27 Cosmederm Technologies Formulations and methods for reducing skin irritation
EP0756866A1 (en) * 1995-07-31 1997-02-05 L'oreal Use of benzoic acid derivatives for stimulating the renew of the epidermis and for treating the skin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
D.F. WILLIAMS: "CHEMISTRY AND TECHNOLOGY OF THE COSMETICS AND TOILETRIES INDUSTRY", 1996, BLACKIE ACADEMIC & PROFESSIONAL, XP002129103 *

Also Published As

Publication number Publication date
JP2002540126A (en) 2002-11-26
FR2791260A1 (en) 2000-09-29
WO2000057836A2 (en) 2000-10-05
ES2250118T3 (en) 2006-04-16
FR2791260B1 (en) 2003-06-06
DE60023467D1 (en) 2005-12-01
EP1165035B1 (en) 2005-10-26
JP4708571B2 (en) 2011-06-22
EP1165035A2 (en) 2002-01-02
DE60023467T2 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
Husein el Hadmed et al. Cosmeceuticals: peptides, proteins, and growth factors
WO2000057836A3 (en) Cosmetic or dermatological compositions containing at least one substance for increasing the functionality and/or expression of cd44 membrane receptors of skin cells
ES2285859T3 (en) COSMETIC OR DERMOFARMACEUTICAL USE OF PEPTIDES FOR THE CICATRIZATION, HYDRATION AND IMPROVEMENT OF THE SKIN ASPECT DURING NATURAL OR ACCELERATED AGING (HELIODERMIA, CONTAMINATION).
ES2421262T3 (en) Composition for personal and cosmetic care containing tetrapeptides with CX1X2G, PX1X2P or PX1X2K units
US20140287006A1 (en) Degradation-Stabilised, Biocompatible Collagen Matrices
ES2129013A1 (en) Use of vitamin c or derivatives or analogues thereof for promoting skin elastin synthesis
CY1108934T1 (en) LOCAL COMPOSITIONS WHICH COMBINE FRUITS Sodium hyaluronic acid and a retinoid
JP2008143903A (en) Cosmetic use of anisic acid to enhance exfoliation
JP2002293747A (en) Skin preparation for external use
KR20230065274A (en) Tissue-Derived Matrikin Compositions and Methods Thereof
KR101165848B1 (en) Cosmetic composition containing enzyme and amino acid
Liu et al. Anti-ageing peptides and proteins for topical applications: A review
KR20060115758A (en) Cosmetic composition containing a protein and an enzyme inhibitor
JP2000273033A (en) Gel comprising natural material
WO2009152205A1 (en) Topical compositions comprising imidazolidinedione analogs and their use to treat or prevent the appearance of skin wrinkling
Morganti et al. Chitin-nanofibrils: a new active cosmetic carrier
EP3490525A1 (en) Skin care products and uses thereof
KR101305274B1 (en) Composition for improving collagen synthesis
KR101218898B1 (en) Composition for improving collagen synthesis
CN105982825A (en) Use of composition in production of cosmetics with moisturizing function
JP2003300818A (en) Cosmetic
JP5226200B2 (en) Sulfated glycosaminoglycan production promoter and skin external preparation containing the same
US20100098732A1 (en) Methods, processes and compositions comprising the protein calmodulin (cam) for treatment of damaged or aging skin, and/or hair loss
JP2006028045A (en) Cosmetic having depilation-promoting action
BRPI0713959A2 (en) topically cosmetic and / or dermatological composition, cosmetic set, cosmetic use of a composition, cosmetic treatment process, and use of at least one hyaluranic acid or derivatives thereof and at least one c-glycoside derivative

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 607587

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09937507

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2000915224

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000915224

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2000915224

Country of ref document: EP